野口 浩司

Medicine and Dentistry

1. Patient 100%
2. Donor 94%
3. Kidney Transplantation 84%
4. Kidney Graft 69%
5. Pancreas Transplantation 65%
6. Graft Survival 43%
7. Transplantation 39%
8. Nephrectomy 37%
9. Therapeutic Procedure 29%
10. Propensity Score Matching 23%
11. T Cell 19%
12. Everolimus 18%
13. Analysis 18%
14. Graft Failure 17%
15. Age 17%
16. Tacrolimus 17%
17. Thrombosis 16%
18. Survival Rate 15%
19. Observational Study 15%
20. Operation Duration 15%
21. Acute Graft Rejection 14%
22. Biopsy 14%
23. Psoas Muscle 14%
24. Pancreas 13%
25. End Stage Renal Disease 12%
26. Allograft 11%
27. Inpatient 11%
28. Cohort Analysis 10%
29. Retrospective Study 10%
30. Serum 10%
31. Development 9%
32. Surgery 9%
33. Blood 9%
34. Nephropathy 9%
35. Cardiovascular Disease 9%
36. Immunosuppressive Treatment 9%
37. Diabetic Nephropathy 8%
38. Follow up 8%
39. Mycophenolate Mofetil 8%
40. Incidence 8%
41. Health Care Cost 8%
42. Adhesive Agent 7%
43. Kidney Pancreas Transplantation 7%
44. BK Virus 7%
45. Complement Component C1q 7%
46. Incisional Hernia 7%
47. Lymphocyte 7%
48. Duodenum Perforation 7%
49. Porphyromonas gingivalis 7%
50. B Cell 7%